← Back to Search

Stepped Care for Binge Eating Disorder: Predicting Response to Minimal Intervention in a Randomized Controlled Trial

N/A
Waitlist Available
Led By George A Tasca, Ph.D,C.Psych
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one and a half years
Awards & highlights
No Placebo-Only Group

Summary

Binge Eating Disorder (BED) affects as many as 3% of women and men in Ontario, 8% of obese individuals, and 30% to 50% of those participating in weight loss programs. BED, the most common eating disorder, is characterized by over-eating with loss of control (i.e., binge eating), but with no purging (e.g., vomiting).Our previous research indicates that the total health care costs for women with BED is 36% higher than the Canadian average for women of a similar age, and that health care costs significantly decreased following intensive treatment at our Centre. The main goal of our study is to inform the development of a stepped care approach to the treatment of BED. Stepped care involves providing easily accessible low intensity treatment first, and then providing more expensive intensive treatment second, if necessary. The second goal is to assess if a second more intensive step of treatment provides added value. Although stepped care for BED is suggested by a number of clinicians and researchers, no study adequately tests predictors of who might benefit from minimal treatment alone and who would require the more intensive second step. The results of this study will guide decision making regarding who benefits from stepped care, and will help to increase the accessibility, availability, and cost effectiveness of psychological treatments for BED.

Eligible Conditions
  • Binge Eating Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one and a half years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to one and a half years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Binge Eating Episodes in the Past 28 Days.
Secondary study objectives
Body Mass Index (BMI).
Center for Epidemiologic Studies Depression Scale (CES-D)
Depression Anxiety and Stress Scales 21(DASS-21)
+11 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Unguided Self-Help, No Further Treatment for 16 WeeksExperimental Treatment1 Intervention
All participants will first receive 10 weeks of unguided self-help (USH), followed by no further treatment for 16 weeks. Participants will be offered a follow up referral to the eating disorders program at The Ottawa Hospital after the 16 week no-treatment period.
Group II: Unguided Self-Help, GPIPExperimental Treatment2 Interventions
All participants will first receive 10 weeks of unguided self-help (USH). For those participants randomized to the USH + Group Psychodynamic Interpersonal Psychotherapy condition, this second step will consist of 16 weekly 90 minute sessions of Group Psychodynamic Interpersonal Psychotherapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group Psychodynamic Interpersonal Psychotherapy
2007
N/A
~110

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
577 Previous Clinical Trials
3,139,798 Total Patients Enrolled
Ontario Mental Health FoundationOTHER_GOV
23 Previous Clinical Trials
3,224 Total Patients Enrolled
George A Tasca, Ph.D,C.PsychPrincipal InvestigatorUniversity of Ottawa, Ottawa Hospital: General Campus
~11 spots leftby Dec 2025